Baker McKenzie advised KD Pharma Group, a global producer of pharmaceutical and nutritional lipids, on the acquisition of dsm-firmenich’s marine lipids business in exchange for a minority stake in KD Pharma Group. The transaction is expected to close towards the end of 2024 and is subject to customary regulatory approvals. The transaction includes dsm-firmenich’s Marine […]
Bär & Karrer advised Deutsche Private Equity (DPE) on the acquisition of a majority stake in IMPAG Group, advised by Lenz & Staehelin. The transaction is subject to clearance by competition authorities and is
Opus (Public) Chartered Issuance SA, Luxembourg, joins deritrade as an issuer for structured products. Opus invests the proceeds from the issuance in financing instruments of various financing partners, depending on the selection of the deritrade
Homburger advises global alternative asset manager Apollo Global Management on the acquisition of The Travel Corporation (TTC), an international travel group. Homburger’s team Daniel Hasler (pictured) led the Homburger team, which includes Marco Rostetter,
CMS advised ACRON and the other previous shareholders on the sale of all shares in ACRON HELVETIA VI Immobilien. CMS’ team A team of CMS Zurich led by corporate/M&A partner Dr Daniel
CMS advised CymbiQ Group, a portfolio company of the German private equity investor capiton, on the sale of Aspectra to the Convotis Group. With the sale of Aspectra – a Zurich-based hosting and managed services provider –
MLL advised KRÜGER GROUP, a German food and beverage manufacturer, producing and selling food products, specialising in beverages, chocolate and sugar confectionery, infant formula, health products, OTC and pharmaceutical products and semi-finished products for
Baker McKenzie advised SPGI Zurich, a member of Intercity Group, on entering into an exclusive partnership with Colliers International. The partnership with one of the world’s largest real estate service providers will come into
BNC, a provider of IT security solutions and services with over 100 employees and locations in Urtenen-Schönbühl, Dübendorf, and Yverdon-les-Bains, has been acquired by fernao Schweiz, advised by Valfor. Advoro acted as legal
Baker McKenzie advised CureVac, a global biopharmaceutical company developing transformative medicines based on messenger ribonucleic acid (mRNA), on restructuring its existing collaboration with GSK into a new licensing agreement, allowing each company to prioritize investment
